Search Results

Acid Concentrate for Bicarbonate Dialysis

The Fresenius Naturalyte® Liquid Acid Concentrates are a modified version of the Fresenius Naturalyte Liquid Acid Concentrates. The technological characteristics of the modified devices are equivalent to those of the unmodified devices.

I am sorry, but based on the provided text, there is no information about acceptance criteria or a study that proves a device meets specific acceptance criteria.

The document is a 510(k) Premarket Notification for "Fresenius Naturalyte® Liquid Acid Concentrates 'Special'". It focuses on establishing substantial equivalence to previously marketed predicate devices. Key sections include:

• Summary of Safety and Effectiveness: This section describes the device, its intended use, and the process to demonstrate substantial equivalence to predicate devices (K810925, K823115, K852310).
• Substantial Equivalence Decision Making Process: This outlines how the new device is compared to the predicate devices based on intended use and technological characteristics. It concludes that the modified device is equivalent and raises no new safety or effectiveness questions.
• Safety Summary: States that the modified concentrates are substantially equivalent in construction, design, materials, and intended use, and that "testing of the modified device indicates that the set is safe and effective for its intended use." However, it does not detail any specific acceptance criteria or the study that generated this "testing" information.
• FDA Response Letter: This letter from the FDA confirms the substantial equivalence determination for the device.

The document does not contain the following information that you requested:

1. A table of acceptance criteria and the reported device performance.
2. Sample sizes used for any test set or data provenance.
3. Number of experts used to establish ground truth or their qualifications.
4. Adjudication method for a test set.
5. Information about a multi-reader multi-case (MRMC) comparative effectiveness study or human reader improvement with AI.
6. Details of a standalone (algorithm only) performance study.
7. The type of ground truth used (e.g., expert consensus, pathology, outcomes data).
8. Sample size for a training set.
9. How ground truth for a training set was established.

This document is a regulatory submission for substantial equivalence based on comparisons to existing devices, rather than a detailed report of performance against specific, quantifiable acceptance criteria.

Ask a specific question about this device